Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Highlights from the Annual Surveillance Report of Drug-Related Risks and Outcomes – United States, 2018
Filetype[PDF-9.32 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
Highlights from the Annual Surveillance Report of Drug-Related Risks and Outcomes – United States, 2018
Details:
  • Supporting Files:
    No Additional Files
    1. Highlights from the Annual Surveillance Report of Drug-Related Risks and Outcomes – United States, 2019
      Corporate Authors:
      National Center for Injury Prevention and Control (U.S.).
      Published Date:
      11/01/2019
      Series:
      Surveillance Report
      Description:
      This is the third annual drug surveillance report summarizing the latest data at the national level for opioid prescribing patterns, drug use, nonfatal overdoses, and fatal overdoses related to the current drug overdose epidemic in the United States.
      File Type:
      Filetype[PDF - 3.40 MB]
You May Also Like:
  1. MMWR. Morbidity and mortality weekly report, Vol. 69, no. 31, August 7, 2020
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    08/07/2020
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 69, no. 31
    File Type:
    Filetype[PDF - 1.00 MB]
  2. Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending August 1, 2020 (Week 31) Table1p Hemolytic uremic syndrome post-diarrheal; Hepatitis (viral, acute, by type)
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    08/06/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 31
    Description:
    2020-31-Table1p -H.pdf
    File Type:
    Filetype[PDF - 113.97 KB]
  3. Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending August 1, 2020 (Week 31) Table1s Invasive pneumococcal disease, all ages
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    08/06/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 31
    Description:
    2020-31-Table1s -H.pdf
    File Type:
    Filetype[PDF - 100.17 KB]
  4. Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending August 1, 2020 (Week 31) Table1q Hepatitis B, perinatal infection; Hepatitis C (viral, acute)
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    08/06/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 31
    Description:
    2020-31-Table1q -H.pdf
    File Type:
    Filetype[PDF - 113.87 KB]
  5. Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending August 1, 2020 (Week 31) Table1m Gonorrhea; Haemophilus influenzae, invasive disease (all ages, all serotypes); Haemophilus influenzae, invasive disease (age <5 years)
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    08/06/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 31
    Description:
    2020-31-Table1m -H.pdf
    File Type:
    Filetype[PDF - 119.93 KB]